Supportive Care in Cancer

, Volume 20, Issue 11, pp 2977–2984 | Cite as

A systematic review of the effect of low-level laser therapy in the management of breast cancer-related lymphedema

  • Mohammed Taher Ahmed OmarEmail author
  • Afaf Ahmed Mohamed Shaheen
  • Hamayun Zafar
Review Article



The purpose of this study was to review the effect of low-level laser therapy (LLLT) in the management of breast cancer-related lymphedema (BCRL).


A systematic review of seven databases for clinical trials for LLLT in the management of BCRL published between 1990 and 2011 was performed.


A total of eight studies on 230 patients were found. The methodological qualities of the selected studies were assessed with the Physiotherapy Evidence Database scale, and the studies were categorized according to Sackett’s levels of evidence. Five studies were graded at evidence level II. Two studies were graded at evidence level III, and the remaining study was graded at evidence level V.


There is moderate to strong evidence for the effectiveness of LLLT for the management of BCRL from five small studies of acceptable methodological quality. A dose of 1–2 J/cm2 per point applied to several points covering the fibrotic area can reduce limb volume following BCRL. Further well-designed, large-scale studies are required to determine more precisely how effective LLLT may be in BCRL.


Breast cancer Lymphedema Low-level laser therapy 


Conflict of interest



  1. 1.
    Clark B, Sttzia J, Harlow W (2005) Incidence and risk of arm edema following treatment for breast cancer: a three-year follow-up study. Q J Med 98:343–348CrossRefGoogle Scholar
  2. 2.
    Ozaslan C, Kuru B (2004) Lymphedema after treatment of breast cancer. Am J Surg 187:69–72PubMedCrossRefGoogle Scholar
  3. 3.
    Lee T, Kilbreath S, Refshauge K, Herbert R, Beith J (2008) Prognosis of the upper limb following surgery and radiation for breast cancer. Breast Cancer Res Treat 110:19–37PubMedCrossRefGoogle Scholar
  4. 4.
    Hayes SC, Janda M, Cornish B, Battistutta D, Newman B (2008) Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol 26:3536–3542PubMedCrossRefGoogle Scholar
  5. 5.
    Petrek JA, Heelan MC (1998) Incidence of breast carcinoma-related lymphedema. Cancer 12(Suppl):2776–2781CrossRefGoogle Scholar
  6. 6.
    Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL (2001) Arm edema in breast cancer patients. J Natl Cancer Inst 93(2):96–111PubMedCrossRefGoogle Scholar
  7. 7.
    Soran A, D’Angelo G, Begovic M, Ardic F, Harlak A, Samuel Wieand H et al (2006) Breast cancer-related lymphedema—what are the significant predictors and how they affect the severity of lymphedema? Breast J12:536–543Google Scholar
  8. 8.
    Casley-Smith JR, Casley-Smith JR (1994) Volume alterations in lymphedema; untreated, and after complex therapy (C.P.T), benzo-pyrones, or both. Lymphology 27(suppl):627–631Google Scholar
  9. 9.
    Karki A, Simonen R, Malkia E, Selfe J (2005) Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation. J Rehabil Med 37:180–188PubMedGoogle Scholar
  10. 10.
    Gossenlink R, Rouffaer L, Vanhelden P, Piot W, Trooster T, Christiaens M (2003) Recovery of upper limb function after axillary dissection. J Surg Oncol 83:204–211CrossRefGoogle Scholar
  11. 11.
    Rietman JS, Dijkstra PU, Geertzen JH, Baas P, De-Vries J, Dolsma WV et al (2004) Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol 11:1018–1024PubMedCrossRefGoogle Scholar
  12. 12.
    Clodius L (2002) Lymphedema common sense. Eur J Plast Surg 25:66–80CrossRefGoogle Scholar
  13. 13.
    Velanovich V, Szymanski W (1999) Quality of life of breast cancer patients in lymphedema. Am J Surg 177:184–187PubMedCrossRefGoogle Scholar
  14. 14.
    Olszewski W (2000) Clinical efficacy of micronized purified flavonoid fraction (MPFF) in edema. Angiology 51:25–29PubMedCrossRefGoogle Scholar
  15. 15.
    Badger CM, Peacock JL, Mortimer PS (2000) A randomized, controlled, parallel-group clinical trial comparing multilayer bandaging followed by hosiery versus hosiery alone in the treatment of patients with lymphedema of the limb. Cancer 88:2832–8327PubMedCrossRefGoogle Scholar
  16. 16.
    Szuba A, Cooke JP, Yousuf S, Rockson SG (2000) Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema. Am J Med 109:296–300PubMedCrossRefGoogle Scholar
  17. 17.
    Dini D, Del Mastro L, Gozza A (1998) The role of pneumatic compression in the treatment of postmastectomy lymphedema. A randomized phase III study. Ann Oncol 9:187–190PubMedCrossRefGoogle Scholar
  18. 18.
    Foldi E (1998) The treatment of lymphedema. Cancer 83:2833–2834PubMedCrossRefGoogle Scholar
  19. 19.
    Casley-Smith J, Casley-Smith JR (1997) The cost efficiencies of various treatments for lymphoedema. In: Casley-Smith J, Casley-Smith JR (eds) Modern treatment for lymphoedema. The Lymphedema Association of Australia, Adelaide, pp 296–304Google Scholar
  20. 20.
    Balzarini A, Pirovano C, Diazzi G et al (1993) Ultrasound therapy of chronic arm lymphedema after surgical treatment of breast cancer. Lymphology 26:128–134PubMedGoogle Scholar
  21. 21.
    Can J, Li S, Cai R, Chang T (1996) Microwave heating in the management of post mastectomy upper limb lymphedema. Ann Plast Surg 36:576–580CrossRefGoogle Scholar
  22. 22.
    Piller NB, Thelander A (1995) Treating chronic postmastectomy lymphedema with low level laser therapy: a cost effective strategy to reduce severity and improve quality of survival. Laser Ther 7:163–168CrossRefGoogle Scholar
  23. 23.
    Piller NB, Thelander A (1998) Treatment of chronic postmastectomy lymphedema with low level laser therapy: a 2.5 year follow-up. Lymphology 31:74–86PubMedGoogle Scholar
  24. 24.
    Carati CJ, Anderson SN, Gannon BJ, Piller NB (2003) Treatment of postmastectomy lymphedema with low-level laser therapy: a double blind, placebo-controlled trial. Cancer 98:1114–1122PubMedCrossRefGoogle Scholar
  25. 25.
    Kaviani A, Fateh M, Nooraie RY, Alinagizadeh MR, Ataie-Fashtami L (2006) Low-level laser therapy in management of postmastectomy lymphedema. Lasers Med Sci 21:90–94PubMedCrossRefGoogle Scholar
  26. 26.
    Kozanoglu E, Basaran S, Paydas S, Sarpel T (2009) Efficacy of pneumatic compression and low-level laser therapy in the treatment of postmastectomy lymphedema: a randomized controlled trial. Clin Rehabil 23:117–124PubMedCrossRefGoogle Scholar
  27. 27.
    Lau RW, Cheing GL (2009) Managing postmastectomy lymphedema with low-level laser therapy. Photomed Laser Surg 27:763–769PubMedCrossRefGoogle Scholar
  28. 28.
    Dirican A, Andacoglu O, Johnson R, McGuire K, Mager L, Soran A (2011) The short-term effects of low-level laser therapy in the management of breast-cancer-related lymphedema. Support Care Cancer 19:685–690PubMedCrossRefGoogle Scholar
  29. 29.
    Omar MT, Ebid AA, El Morsy AM (2011) Treatment of post-mastectomy lymphedema with laser therapy: double blind placebo control randomized study. J Surg Res 165:82–90CrossRefGoogle Scholar
  30. 30.
    Lievens PC (1985) The influence of laser-irradiation on the motoricity of the lymphatic system and on the wound healing process. In: Proceedings from the International Congress on Laser in Medicine and Surgery, Bologna, 26–28 June: 171–4Google Scholar
  31. 31.
    Lievens PC (1991) The effect of combined HeNe and I.R. laser treatment on the regeneration of the lymphatic system during the process of wound healing. Lasers Med Sci 6:93–99Google Scholar
  32. 32.
    Cormier J, Feldman J, Askew A, Beck M, Bernas M, Francis K et al (2010) ALFP to update the best practice document. J Lymphedema 5:68–71Google Scholar
  33. 33.
    Moseley AL, Carati CJ, Piller NB (2007) A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment. Ann Oncol 18:639–646PubMedCrossRefGoogle Scholar
  34. 34.
    Sackett DL (1989) Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 95(suppl2):2S–4SPubMedGoogle Scholar
  35. 35.
    Se S, Richardson WS, Glasziou P, Haynes RB (2002) Evidence based medicine: how to practice and teach EBM, 3rd edn. Elsevier Churchill Livingstone, EdinburghGoogle Scholar
  36. 36.
    Sitzia J, Stanton AB, Badger C (1997) A review of outcome indicators in the treatment of chronic limb edema. Clin Rehabil 11:181–191PubMedCrossRefGoogle Scholar
  37. 37.
    Armer J, Fu MR (2005) Age differences in post-breast cancer lymphedema signs and symptoms. Cancer Nurs 28(3):200–207PubMedCrossRefGoogle Scholar
  38. 38.
    Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM et al (2006) Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13(4):491–500PubMedCrossRefGoogle Scholar
  39. 39.
    Piper MC (1990) Efficacy of physical therapy: rate of motor development in children with cerebral palsy. Pediatr Phys Ther 2:126–130CrossRefGoogle Scholar
  40. 40.
    Bobyd S, Brooks D, Agnew-Coughlin J, Ashwell J (1994) Evaluation of the literature on the effectiveness of physical therapy modalities in the management of children with cystic fibrosis. Pediatr Phys Ther 6:70–74Google Scholar
  41. 41.
    Verhagen A, de Vet H, de Bie R et al (1998) The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 51:1235–1241PubMedCrossRefGoogle Scholar
  42. 42.
    Maher CG, Sherrington C, Herbert R et al (2003) Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther 83:713–721PubMedGoogle Scholar
  43. 43.
    Harris SR (1996) How should treatments be critiqued for scientific merit? Phys Ther 76:175–181PubMedGoogle Scholar
  44. 44.
    Oasevich IA, Shargorodskii AG (1999) Low intensity infrared laser in the diagnosis and combined treatment of acute non-specific lymphadenitis of the face and neck in children. Stomatologia 78:28–30Google Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Mohammed Taher Ahmed Omar
    • 1
    • 2
    Email author
  • Afaf Ahmed Mohamed Shaheen
    • 2
    • 3
  • Hamayun Zafar
    • 4
    • 5
  1. 1.Physical Therapy Department for Surgery, Faculty of Physical TherapyCairo UniversityGizaEgypt
  2. 2.Rehabilitation Research ChairKing Saud UniversityRiyadhSaudi Arabia
  3. 3.Basic Sciences Department, Faculty of Physical TherapyCairo UniversityGizaEgypt
  4. 4.Department of Rehabilitation Health Sciences, College of Applied Medical SciencesKing Saud UniversityRiyadhSaudi Arabia
  5. 5.Department of Odontology, Clinical Oral PhysiologyUmeå UniversityUmeåSweden

Personalised recommendations